Status:
COMPLETED
Does Intraperitoneal Instillation of Lidocaine at Cesarean Delivery Improve Postoperative Analgesia?
Lead Sponsor:
Samuel Lunenfeld Research Institute, Mount Sinai Hospital
Conditions:
Pain
Eligibility:
FEMALE
18-50 years
Phase:
NA
Brief Summary
The instillation of local anesthetic into the peritoneum has been found to be safe and effective in reducing postoperative pain and morphine consumption after abdominal surgery. A review of studies re...
Detailed Description
Postoperative pain after cesarean delivery can have a significant negative impact on the mother's ability to care for her newborn and lead to complications such as thromboembolism, chronic pain, and d...
Eligibility Criteria
Inclusion
- ASA I or II patients
- 18-50 years of age
- Term pregnancy
- Singleton pregnancy
- Spinal anesthetic
- Pfannenstiel incision
- Patients who have given pre-operative informed written consent
Exclusion
- Patients who refuse or are unable to give consent
- ASA \>2
- Multiple gestation
- Chronic pain
- BMI \>40
- Contraindication to acetaminophen or non-steroidal anti-inflammatory drugs
Key Trial Info
Start Date :
November 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2015
Estimated Enrollment :
204 Patients enrolled
Trial Details
Trial ID
NCT02264795
Start Date
November 1 2014
End Date
November 1 2015
Last Update
May 3 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mount Sinai Hospital
Toronto, Ontario, Canada, M5G1X5